SEC Form 4 · accession 0001628280-26-042506

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jun 9, 2026

Accepted (ET)

Jun 11, 2026 · 4:10 pm EDT

Rule 10b5-1 plan

yes — trade under a plan

Issuer CIK

0001077183

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jun 9, 2026	S	5,307	$11.29	D	91,422	D
Common Stock	holding	—	—		—	7,000	I	Lynn Tetrault Rollover IRA

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)	$22.52	holding	—	—	—	Jun 6, 2020	Jun 6, 2026	Common Stock	2,136	2,136	D
Stock Option (Right to Buy)	$28.54	holding	—	—	—	May 28, 2021	May 28, 2027	Common Stock	3,448	3,448	D
Stock Option (Right to Buy)	$40.90	holding	—	—	—	Jun 2, 2022	Jun 2, 2028	Common Stock	3,714	3,714	D
Stock Option (Right to Buy)	$41.76	holding	—	—	—	Oct 11, 2022	Oct 11, 2028	Common Stock	972	972	D
Stock Option (Right to Buy)	$8.10	holding	—	—	—	Jun 10, 2023	Jun 10, 2029	Common Stock	13,882	13,882	D
Stock Option (Right to Buy)	$14.82	holding	—	—	—	Aug 10, 2024	Aug 10, 2033	Common Stock	8,353	8,353	D
Stock Option (Right to Buy)	$13.71	holding	—	—	—	Jun 1, 2025	Jun 1, 2034	Common Stock	8,672	8,672	D
Stock Option (Right to Buy)	$7.28	holding	—	—	—	Jun 1, 2026	Jun 1, 2035	Common Stock	16,107	16,107	D
Stock Option (Right to Buy)	$10.52	holding	—	—	—	Jun 1, 2027	Jun 1, 2036	Common Stock	11,069	11,069	D
Restricted Stock Unit^F1	$0.00	holding	—	—	—	Jun 1, 2027	—	Common Stock	15,970	15,970	D